EFO Inhalation Capsule

EFO 12 mcg Inhalation Capsule সম্পর্কে

EFO 12 mcg Inhalation Capsule একটি Inhalation Capsule ঔষধ, যার জেনেরিক নাম Formoterol Fumarate এবং শক্তি ১২ mcg। EFO প্রস্তুত করেছে Square Pharmaceuticals PLC। EFO-এর সাথে Formoterol Fumarate-এর অন্য ব্র্যান্ডের দাম নিচে তুলনা করে দেখুন। ডাক্তারের প্রেসক্রিপশন মেনে চলুন এবং অন্য ব্র্যান্ড খাওয়া যাবে কি না তা ফার্মাসিস্টের কাছ থেকে জেনে নিন।

EFO 12 mcg Inhalation Capsule কী?

EFO is a brand of formoterol fumarate inhalation capsules, 12 mcg, made by Square Pharmaceuticals PLC. Formoterol fumarate belongs to a group called long-acting selective β-adrenoceptor stimulants, often described as long-acting beta-agonists. It works mainly in the lungs to help open the airways. It is not a stand-alone asthma treatment; it is used together with a long-term asthma control medicine, such as an inhaled corticosteroid. The doctor decides the dose and how long to use it, based on the person's condition. Always follow the prescribed instructions and ask the doctor or pharmacist if anything is unclear.

EFO-এর ব্যবহার

EFO 12 mcg inhalation capsules are used for asthma and to prevent bronchospasm in people with reversible obstructive airways disease. They are intended only as add-on therapy with a long-term asthma control medicine, such as an inhaled corticosteroid. They are not a replacement for that controller medicine. The doctor decides whether this medicine is suitable and how it fits into the overall treatment plan.

EFO কীভাবে ব্যবহার করবেন

EFO is an inhalation capsule, so it is used with a suitable inhalation device as explained by the doctor or pharmacist. The dose and how often to use it are set by the doctor; never change the dose yourself. Do not swallow the capsule. If you are unsure how to load or inhale the capsule, ask your doctor or pharmacist for a demonstration. Keep to the prescribed schedule and do not stop the controller medicine unless told to.

EFO-এর পার্শ্বপ্রতিক্রিয়া

Like all medicines, EFO can cause side effects. Common ones include tremor, dizziness, headache, and insomnia. Some people may experience chest pain, a fast heartbeat, or changes in blood pressure. Breathing problems such as paradoxical bronchospasm or a severe asthma attack can occur. Other possible effects include low potassium, high blood sugar, and metabolic acidosis. If you notice any side effect, especially worsening breathing, tell your doctor or pharmacist promptly.

সতর্কতা ও নিরাপত্তা

EFO should be avoided by anyone allergic to formoterol or any ingredient. Tell the doctor before use if you have thyrotoxicosis, severe heart problems such as ischaemic heart disease or irregular heartbeat, a prolonged QT interval, diabetes, or severe heartburn. The doctor will decide if it is suitable during pregnancy or breastfeeding; pregnancy category C means animal studies showed harm but human data are limited. Do not start or increase the dose during an asthma flare-up. Children should use it only as the doctor advises. Ask your doctor or pharmacist about interactions with other medicines.

সাধারণ প্রশ্ন

Who should avoid EFO or ask the doctor first?

People allergic to formoterol or any ingredient should avoid it. Ask the doctor first if you have heart problems, an irregular heartbeat, a prolonged QT interval, thyroid problems, diabetes, or severe heartburn. Also check before use if you are pregnant or breastfeeding, or if you take other medicines, as interactions are possible.

What is EFO used for and what kind of medicine is it?

EFO 12 mcg inhalation capsules contain formoterol fumarate, a long-acting bronchodilator. It is used for asthma and to prevent bronchospasm in reversible obstructive airways disease. It is not used alone; it is taken together with a long-term asthma control medicine such as an inhaled corticosteroid. The doctor decides the dose.

How should I store EFO inhalation capsules?

Before dispensing, store in a refrigerator between 2°C and 8°C. After you receive it, store at 20°C to 25°C. Keep the capsules in their original packaging, away from moisture and out of reach of children. Do not use after the expiry date. If you are unsure, ask your pharmacist.

Can I use EFO during an asthma attack?

EFO is a long-acting medicine and is not meant for immediate relief of sudden breathing problems. It should not be started or increased during an asthma flare-up. Always have a fast-acting reliever inhaler available as prescribed. If your breathing worsens, seek medical help right away and follow your doctor's advice.

নির্দেশনা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Treatment of Asthma: Formoterol Fumarate is indicated for the treatment of asthma and in the prevention of bronchospasm only as concomitant therapy with a long-term asthma control medication, such as an inhaled corticosteroid, in adults and children 5 years of age and ... Read moreTreatment of Asthma: Formoterol Fumarate is indicated for the treatment of asthma and in the prevention of bronchospasm only as concomitant therapy with a long-term asthma control medication, such as an inhaled corticosteroid, in adults and children 5 years of age and older with reversible obstructive airways disease, including patients with symptoms of nocturnal asthma.

Prevention of Exercise-Induced Bronchospasm: Formoterol Fumarate is also indicated for the acute prevention of exercise-induced bronchospasm in adults and children 5 years of age and older, when administered on an occasional, as-needed basis. Use of Formoterol Fumarate as a single agent for the prevention of exercise-induced bronchospasm may be clinically indicated in patients who do not have persistent asthma. In patients with persistent asthma, use of Formoterol Fumarate for the prevention of exercise-induced bronchospasm may be clinically indicated, but the treatment of asthma should include a long-term asthma control medication, such as an inhaled corticosteroid.

Maintenance Treatment of Chronic Obstructive Pulmonary Disease: Formoterol Fumarate is indicated for the long-term, twice daily (morning and evening) administration in the maintenance treatment of bronchoconstriction in patients with Chronic Obstructive Pulmonary Disease including chronic bronchitis and emphysema.

ফার্মাকোলজি

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Formoterol fumarate is a long-acting β2-adrenergic receptor agonist (β2-agonist). Inhaled formoterol fumarate acts locally in the lung as a bronchodilator. In vitro studies have shown that formoterol has more than 200-fold greater agonist activity at β2-receptors than at β1-receptors. Although β2-receptors are the predominant adrenergic receptors in bronchial smooth muscle and β1-receptors are the predominant receptors in the heart, there are also β2-receptors in the human heart comprising 10%-50% of the total beta-adrenergic receptors. The precise function of these receptors has not been established, but they raise the possibility that even highly selective β2-agonists may have cardiac effects.

The pharmacologic effects of β2-adrenoceptor agonist drugs, including formoterol, are at least in part attributable to stimulation of intracellular adenyl cyclase, the enzyme that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic-3', 5'-adenosine monophosphate (cyclic AMP). Increased cyclic AMP levels cause relaxation of bronchial smooth muscle and inhibition of release of mediators of immediate hypersensitivity from cells, especially from mast cells.

In vitro tests show that formoterol is an inhibitor of the release of mast cell mediators, such as histamine and leukotrienes, from the human lung. Formoterol also inhibits histamine-induced plasma albumin extravasation in anesthetized guinea pigs and inhibits allergen-induced eosinophil influx in dogs with airway hyper-responsiveness. The relevance of these in vitro and animal findings to humans is unknown.

মাত্রা ও সেবনবিধি

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Inhalation Acute bronchospasm; Reversible airways obstruction:
  • As inhalation cap: 12 mcg twice daily, up to 24 meg twice daily in severe cases.
  • As dry powder inhaler: 6 or 12 mcg 1 -2 times/day, up to to 24 mcg twice daily in sever cases. As metered doses from aerosol inhaler: 12 or 24 mcg twice daily.
Prevention of exercise-induced bronchospasm: 6 or 12 mcg at least 15 mins before exercise. Additional doses may be given 12 hr later.

ঔষধের মিথষ্ক্রিয়া

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Concomitant treatment with xanthine derivatives, steroids or diuretics may potentiate a possible hypokalaemic effect of beta-agonists. Increased susceptibility to cardiac arrhythmias in patients treated with digitalis. Concomitant use with quinidine, disopyramide, procainamide, phenothiazines, antihistamines, MAOI or TCAs can prolong the QT-interval and increase the risk of ventricular arrhythmias. L-dopa, L-thyroxine, oxytocin and alcohol can impair cardiac tolerance towards beta2-sympathomimetics. beta-adrenergic blockers can inhibit the effect of formoterol. Increased risk of arrhythmias in patients receiving concomitant anaesthesia with halogenated hydrocarbons.

পার্শ্ব প্রতিক্রিয়া

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Common side effects are Viral infection, Bronchitis, Chest infection, Dyspnea , Chest pain, Tremor, Dizziness, Angina, Arrhythmias, Hypo/hypertension, Tachycardia, Hypokalemia, Hyperglycemia, Metabolic acidosis, Headache, Insomnia, Paradoxical bronchospasm, Severe asthma exacerbation

গর্ভাবস্থায় ও স্তন্যদানকালে

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Pregnancy Category-C. Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks

Lactation: Not known if it is excreted in breast milk or not.

সতর্কতা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Thyrotoxicosis; severe CV disorders e.g. ischaemic heart disease, tachyarrhythmias or severe heart burn; prolonged QT-interval. DM; pregnancy; lactation; children, do not initiate or increase the dose during an exacerbation. May produce paradoxical bronchospasm.

সংরক্ষণ

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Prior to dispensing: Store in a refrigerator, 2°C to 8°C
After dispensing to patient: Store at 20°C to 25°C

ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।